No CrossRef data available.
Article contents
Lipid-lowering drugs and mortality
Published online by Cambridge University Press: 03 January 2018
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Columns
- Information
- Copyright
- Copyright © 1997 The Royal College of Psychiatrists
References
Barker, D. J. P., Marty, C. N., Osmond, C., et al (1993) Growth in utero and serunn cholesterol concentrations in adult life. British Medical Journal. 307, 1527.CrossRefGoogle ScholarPubMed
Barker, D. J. P., Marty, C. N., Osmond, C., Rodin, I.
et al (1995) Low weight gain in infancy and suicide in adult life. British Medical Journal, 311. 1203.CrossRefGoogle ScholarPubMed
Boston, P. F., Dursun, S. M. & Revaley, M. A. (1996) Cholesterol and mental disorder. British Journal of Psychiatry
169, 682–689.Google Scholar
McLoughlin, I. & Charke, P. (1989) Lipid-lowering drugs (letter). British Journal of Psychiatry, 154, 275–276.Google Scholar
Sacks, F. M., Pfeffer, M. A., Moya, L. A., et al (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New England Journal of Medicine. 335, 1001–1009.Google Scholar
Scandinavian Simvastatin Survival Study Group (1995) Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet. 345, 1274.Google Scholar
Shapherd, J., Cobba, S. M., Ford, I., et al (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New England Journal of Medicine, 333, 1301–1307.Google Scholar
Wardle, J., Armitage, J., Collins, R., et al (1996) Randomised placebo controlled trial of effect on nriood of lowering cholesterol concentration. British Medical Journal, 313, 75–78.Google Scholar
You have
Access
eLetters
No eLetters have been published for this article.